Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Stereotaxis Inc

Market Cap 184M 160M 148M 139M 260M 17.33B 262M 1.76B 682M 8.53B 690M 675M 29.63B P/E 2026 *
-9.4x
P/E 2027 * -12.5x
Enterprise Value 184M 160M 148M 139M 260M 17.33B 262M 1.76B 682M 8.53B 690M 675M 29.63B EV / Sales 2026 *
4.66x
EV / Sales 2027 * 3.45x
Free-Float
84.63%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 2017-02-02
Director of Finance/CFO 57 2019-09-30
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 79 2005-01-31
Chairman - 2017-02-02
Director/Board Member 71 2016-09-28
Change 5-day change 1-year change 3-year change Capi.($)
-7.43%-2.84% - - 184M
+0.63%-1.01%+18.35%-13.53% 173B
+1.14%-1.04%-20.16%+23.51% 144B
-0.33%-1.63%-8.88%-26.73% 125B
+0.76%-3.45%-55.32%-16.62% 67.32B
+0.78%+2.64%+18.09%-4.98% 50.3B
-0.58%-1.16%-25.42%-34.65% 43.8B
+2.20%-2.14%+9.99%+4.90% 35.89B
-0.44%-0.03%+4.74%+32.04% 34.9B
+0.72%-5.51%-14.33%-21.69% 28.02B
Average -0.26%-1.86%-8.11%-6.42% 78.04B
Weighted average by Cap. +0.54%-1.89%-6.63%-6.41%

Financials

2026 *2027 *
Net sales 39.4M 34.36M 31.77M 29.78M 55.76M 3.72B 56.2M 377M 146M 1.83B 148M 145M 6.35B 53.28M 46.46M 42.96M 40.26M 75.39M 5.02B 75.99M 510M 198M 2.47B 200M 196M 8.59B
Net income -19.4M -16.92M -15.64M -14.66M -27.45M -1.83B -27.67M -186M -71.97M -901M -72.81M -71.25M -3.13B -13.62M -11.88M -10.99M -10.3M -19.28M -1.28B -19.43M -130M -50.55M -633M -51.14M -50.04M -2.2B
Net Debt - -
Logo Stereotaxis Inc
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!